74 related articles for article (PubMed ID: 8316990)
1. [Insufficient effect of nortriptyline in a rapid metabolizer of sparteine].
Stage KB; Brøsen K
Ugeskr Laeger; 1993 May; 155(20):1561-3. PubMed ID: 8316990
[TBL] [Abstract][Full Text] [Related]
2. [Severe nortriptyline poisoning in poor metabolizers of the sparteine type].
Petersen P; Brøsen K
Ugeskr Laeger; 1991 Feb; 153(6):443-4. PubMed ID: 2000655
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test.
Laine K; Tybring G; Härtter S; Andersson K; Svensson JO; Widén J; Bertilsson L
Clin Pharmacol Ther; 2001 Oct; 70(4):327-35. PubMed ID: 11673748
[TBL] [Abstract][Full Text] [Related]
4. Relationship of hydroxynortriptyline to nortriptyline concentration and creatinine clearance in depressed elderly outpatients.
Schneider LS; Cooper TB; Suckow RF; Lyness SA; Haugen C; Palmer R; Sloane RB
J Clin Psychopharmacol; 1990 Oct; 10(5):333-7. PubMed ID: 2258449
[TBL] [Abstract][Full Text] [Related]
5. Effects of the postpartum period on nortriptyline pharmacokinetics.
Wisner KL; Perel JM; Peindl KS; Findling RL; Hanusa BH
Psychopharmacol Bull; 1997; 33(2):243-8. PubMed ID: 9230637
[TBL] [Abstract][Full Text] [Related]
6. Steady-state plasma levels of E- and Z-10-OH-nortriptyline in nortriptyline-treated patients: significance of concurrent medication and the sparteine oxidation phenotype.
Gram LF; Brøsen K; Kragh-Sørensen P; Christensen P
Ther Drug Monit; 1989 Sep; 11(5):508-14. PubMed ID: 2815225
[TBL] [Abstract][Full Text] [Related]
7. Time course of enzyme induction in humans: effect of pentobarbital on nortriptyline metabolism.
von Bahr C; Steiner E; Koike Y; Gabrielsson J
Clin Pharmacol Ther; 1998 Jul; 64(1):18-26. PubMed ID: 9695715
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.
Prochazka AV; Kick S; Steinbrunn C; Miyoshi T; Fryer GE
Arch Intern Med; 2004 Nov; 164(20):2229-33. PubMed ID: 15534159
[TBL] [Abstract][Full Text] [Related]
9. Assessment of individual CYP2D6 activity in extensive metabolizers with renal failure: comparison of sparteine and dextromethorphan.
Kévorkian JP; Michel C; Hofmann U; Jacqz-Aigrain E; Kroemer HK; Peraldi MN; Eichelbaum M; Jaillon P; Funck-Brentano C
Clin Pharmacol Ther; 1996 May; 59(5):583-92. PubMed ID: 8646830
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the CYP2D6 gene mutations and their consequences for enzyme function in a West African population.
Griese EU; Asante-Poku S; Ofori-Adjei D; Mikus G; Eichelbaum M
Pharmacogenetics; 1999 Dec; 9(6):715-23. PubMed ID: 10634134
[TBL] [Abstract][Full Text] [Related]
11. Concomitant intake of nortriptyline and carbamazepine.
Brøsen K; Kragh-Sørensen P
Ther Drug Monit; 1993 Jun; 15(3):258-60. PubMed ID: 8333008
[TBL] [Abstract][Full Text] [Related]
12. [Psychiatric manifestations of vitamin B12 deficiency: a case report].
Durand C; Mary S; Brazo P; Dollfus S
Encephale; 2003; 29(6):560-5. PubMed ID: 15029091
[TBL] [Abstract][Full Text] [Related]
13. High initial nortriptyline doses in the treatment of depression.
Warner MD; Griffin M; Peabody CA
J Clin Psychiatry; 1993 Feb; 54(2):67-9. PubMed ID: 8444823
[TBL] [Abstract][Full Text] [Related]
14. Drug interaction between rifampin and nortriptyline: a case report.
Bebchuk JM; Stewart DE
Int J Psychiatry Med; 1991; 21(2):183-7. PubMed ID: 1894457
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant treatment of tinnitus patients: report of a randomized clinical trial and clinical prediction of benefit.
Dobie RA; Sakai CS; Sullivan MD; Katon WJ; Russo J
Am J Otol; 1993 Jan; 14(1):18-23. PubMed ID: 8424470
[TBL] [Abstract][Full Text] [Related]
16. Continuation/maintenance treatment with nortriptyline versus combined nortriptyline and ECT in late-life psychotic depression: a two-year randomized study.
Navarro V; Gastó C; Torres X; Masana G; Penadés R; Guarch J; Vázquez M; Serra M; Pujol N; Pintor L; Catalán R
Am J Geriatr Psychiatry; 2008 Jun; 16(6):498-505. PubMed ID: 18515694
[TBL] [Abstract][Full Text] [Related]
17. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
[TBL] [Abstract][Full Text] [Related]
18. Substantial rise in sparteine metabolic ratio during haloperidol treatment.
Gram LF; Debruyne D; Caillard V; Boulenger JP; Lacotte J; Moulin M; Zarifian E
Br J Clin Pharmacol; 1989 Feb; 27(2):272-5. PubMed ID: 2713222
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of nortriptyline penetration through human epidermis: influence of chemical enhancers and iontophoresis.
Merino V; Micó-Albiñana T; Nácher A; Díez-Sales O; Herráez M; Merino-Sanjuán M
J Pharm Pharmacol; 2008 Apr; 60(4):415-20. PubMed ID: 18380912
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of a CYP2D6 poor metabolizer--a patient with schizophrenia on risperidone treatment.
Bozina N; Jovanović N; Lovrić M; Medved V
Ther Drug Monit; 2008 Dec; 30(6):748-51. PubMed ID: 18806696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
